Literature DB >> 944701

The germinal vesicle nucleus of Xenopus laevis oocytes as a selective storage receptacle for proteins.

R W Merriam, R J Hill.   

Abstract

The amorphous nucleoplasm of the germinal vesicle nucleus of Xenopus laevis oocytes has been selectively extracted under conditions which leave the nuclear formed elements morphologically intact. The nucleoplasm contains about 97% of the total nuclear proteins and on SDS-polyacrylamide gels some 68 polypeptides can be distinguished. On the basis of solubility differences, the nucleoplasmic proteins can be classified into two categories. The first consists of soluble or easily solubilized proteins which comprise about 34 polypeptides making up 87% of the nucleoplasm. A few of these proteins show electrophoretic mobilities similar to those of soluble proteins of the cytoplasm, but most are unique to the nucleus. The residual 13% of the nucleoplasmic proteins are tightly bound to a nucleoplasmic gel and can be extracted only by solubilizing the gel. The solubility characteristics of the proteinaceous gel suggest a complex held together by salt, nonpolar, hydrogen, and possibly disulfide bonding. Some 34 polypeptides can be distinguished in this gel fraction, including prominent and highly enriched polypeptides of about 115,000 and 46,000 daltons. The relatively soluble fraction of the nucleoplasm does not contain informofers and contains little or no nucleic acid. Evidence is presented that if histones are present in the germinal vesicle, they can comprise no more than about 8% of the total protein. The possibility is discussed that the unique polypeptides of the nucleoplasm may be sequestered there by selective adsorption to or in the nuclear gel.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 944701      PMCID: PMC2109705          DOI: 10.1083/jcb.69.3.659

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  19 in total

1.  Cytoplasmic control of nuclear DNA synthesis during early development of Xenopus laevis: a cell-free assay.

Authors:  R M Benbow; C C Ford
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Biological properties of a presumptive morphogenetic determinant from the amphibian oocyte germinal vesicle nucleus.

Authors:  G M Malacinski
Journal:  Cell Differ       Date:  1974-06

4.  Nuclear transplantation and the control of gene activity in animal development.

Authors:  J B Gurdon
Journal:  Proc R Soc Lond B Biol Sci       Date:  1970-12-01

5.  Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.

Authors:  J N Dumont
Journal:  J Morphol       Date:  1972-02       Impact factor: 1.804

6.  Histone synthesis in early amphibian development: histone and DNA syntheses are not co-ordinated.

Authors:  E D Adamson; H R Woodland
Journal:  J Mol Biol       Date:  1974-09-15       Impact factor: 5.469

7.  RNA polymerases in the germinal vesicle contents of Rana pipiens oocytes.

Authors:  P M Wassarman; T G Hollinger; L D Smith
Journal:  Nat New Biol       Date:  1972-12-13

8.  Proteins associated with heterogeneous nuclear RNA of newt oocytes.

Authors:  J Sommerville; R J Hill
Journal:  Nat New Biol       Date:  1973-09-26

9.  Protein migration into nuclei. I. Frog oocyte nuclei in vivo accumulate microinjected histones, allow entry to small proteins, and exclude large proteins.

Authors:  W M Bonner
Journal:  J Cell Biol       Date:  1975-02       Impact factor: 10.539

10.  Nonhistone proteins of the oocyte nucleus of the newt.

Authors:  R J Hill; K Maundrell; H G Callan
Journal:  J Cell Sci       Date:  1974-06       Impact factor: 5.285

View more
  12 in total

1.  A karyophilic signal sequence in adenovirus type 5 E1A is functional in Xenopus oocytes but not in somatic cells.

Authors:  J M Slavicek; N C Jones; J D Richter
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

Review 2.  Nucleocytoplasmic RNA transport.

Authors:  G A Clawson; C M Feldherr; E A Smuckler
Journal:  Mol Cell Biochem       Date:  1985-07       Impact factor: 3.396

3.  Tissue specific nuclear antigens in the germinal vesicle ofXenopus laevis oocytes.

Authors:  Christine Dreyer; Helen Singer; Peter Hausen; Ursula Müller; Elisabeth Siegel
Journal:  Wilehm Roux Arch Dev Biol       Date:  1981-07

4.  In vitro release of alpha 1-acid glycoprotein RNA sequences shows fidelity with the acute phase response in vivo.

Authors:  G A Clawson; J Button; C H Woo; Y C Liao; E A Smuckler
Journal:  Mol Biol Rep       Date:  1986       Impact factor: 2.316

5.  Mammalian nuclear transplantation to Germinal Vesicle stage Xenopus oocytes - a method for quantitative transcriptional reprogramming.

Authors:  R P Halley-Stott; V Pasque; C Astrand; K Miyamoto; I Simeoni; J Jullien; J B Gurdon
Journal:  Methods       Date:  2010-02-01       Impact factor: 3.608

6.  Immunological identification and localization of the predominant nuclear protein of the amphibian oocyte nucleus.

Authors:  G Krohne; W W Franke
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

7.  Protein loss during nuclear isolation.

Authors:  P L Paine; C F Austerberry; L J Desjarlais; S B Horowitz
Journal:  J Cell Biol       Date:  1983-10       Impact factor: 10.539

8.  A monoclonal antibody against the nuclear pore complex inhibits nucleocytoplasmic transport of protein and RNA in vivo.

Authors:  C Featherstone; M K Darby; L Gerace
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

9.  Mechanism for the selection of nuclear polypeptides in Xenopus oocytes.

Authors:  C M Feldherr; J Pomerantz
Journal:  J Cell Biol       Date:  1978-07       Impact factor: 10.539

10.  Actin in Xenopus oocytes. II. Intracellular distribution and polymerizability.

Authors:  R W Merriam; T G Clark
Journal:  J Cell Biol       Date:  1978-05       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.